Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis

JOURNAL ARTICLE published 9 November 2021 in Neurology

Authors: Steve Simpson-Yap | Edward De Brouwer | Tomas Kalincik | Nick Rijke | Jan A. Hillert | Clare Walton | Gilles Edan | Yves Moreau | Tim Spelman | Lotte Geys | Tina Parciak | Clement Gautrais | Nikola Lazovski | Ashkan Pirmani | Amin Ardeshirdavanai | Lars Forsberg | Anna Glaser | Robert McBurney | Hollie Schmidt | Arnfin B. Bergmann | Stefan Braune | Alexander Stahmann | Rodden Middleton | Amber Salter | Robert J. Fox | Anneke van der Walt | Helmut Butzkueven | Raed Alroughani | Serkan Ozakbas | Juan I. Rojas | Ingrid van der Mei | Nupur Nag | Rumen Ivanov | Guilherme Sciascia do Olival | Alice Estavo Dias | Melinda Magyari | Doralina Brum | Maria Fernanda Mendes | Ricardo N. Alonso | Richard S. Nicholas | Johana Bauer | Aníbal Sebastián Chertcoff | Anna Zabalza | Georgina Arrambide | Alexander Fidao | Giancarlo Comi | Liesbet Peeters